Arturo Zazpe Selected Research

Inflammation (Inflammations)

12/2022	The Synthetic Flavonoid Hidrosmin Improves Endothelial Dysfunction and Atherosclerotic Lesions in Diabetic Mice.
11/2021	Nephroprotective Effects of Synthetic Flavonoid Hidrosmin in Experimental Diabetic Nephropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arturo Zazpe Research Topics

Disease

2	Inflammation (Inflammations) 12/2022 - 11/2021
1	Atherosclerotic Plaque (Atheroma) 12/2022
1	Type 2 Diabetes Mellitus (MODY) 12/2022
1	Hyperglycemia 12/2022
1	Atherosclerosis 12/2022
1	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 11/2022
1	Albuminuria 11/2021
1	Diabetic Nephropathies (Diabetic Nephropathy) 11/2021
1	Melanoma (Melanoma, Malignant) 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Neoplasms (Cancer) 01/2018
1	Hypothermia 03/2007
1	Catalepsy 07/2006
1	Tremor (Tremors) 07/2006

Drug/Important Bio-Agent (IBA)

2	FlavonoidsIBA 12/2022 - 11/2021
2	hidrosmin (F 117)IBA 12/2022 - 11/2021
1	ApolipoproteinsIBA 12/2022
1	LipidsIBA 12/2022
1	Streptozocin (Streptozotocin)FDA Link 12/2022
1	Oxidants (Oxidizing Agents)IBA 12/2022
1	Leptin ReceptorsIBA 12/2022
1	Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA 11/2022
1	bilastineIBA 11/2022
1	AlbuminsIBA 11/2021
1	CreatinineIBA 11/2021
1	benzylamineIBA 01/2018
1	LuciferasesIBA 01/2018
1	CateninsIBA 01/2018
1	5-HT1A Serotonin ReceptorIBA 03/2007
1	8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)IBA 07/2006
1	6- methyl- 2- (4- (naphthylpiperazin- 1- yl)butyl)- 3- (2H)- pyridazinoneIBA 07/2006
1	Clozapine (Clozaril)FDA LinkGeneric 07/2006
1	Haloperidol (Haldol)FDA LinkGeneric 07/2006
1	Antipsychotic Agents (Antipsychotics)IBA 07/2006
1	Tacrine (Cognex)FDA Link 07/2006

Therapy/Procedure

1	Oral Administration 11/2021